S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
The #1 Crypto for 2024 (Ad)
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
[Urgent!] Generational Wealth Gameplan (Ad)
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
The #1 Crypto for 2024 (Ad)
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
[Urgent!] Generational Wealth Gameplan (Ad)
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
The #1 Crypto for 2024 (Ad)
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
[Urgent!] Generational Wealth Gameplan (Ad)
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
Stock market today: Wall Street rises in premarket as bond markets stabilize and earnings roll in
The #1 Crypto for 2024 (Ad)
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
Abbott Laboratories Outlook is Healthy: Buy the Dip
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
United Airlines Soars on Earnings Beat
[Urgent!] Generational Wealth Gameplan (Ad)
CSX profit drops 10% despite railroad delivering 3% more freight in first quarter
These are the Top 4 Stocks for Buybacks in 2024
Free Trial
NYSEAMERICAN:EVO

Eaton Vance Ohio Municipal Income Trust (EVO) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free EVO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$7.02
▼
$7.24
50-Day Range
N/A
52-Week Range
$11.74
▼
$13.11
Volume
55,678 shs
Average Volume
24,684 shs
Market Capitalization
$2.56 billion
P/E Ratio
38.11
Dividend Yield
N/A
Price Target
$14.50
Stock AnalysisAnalyst ForecastsHeadlines

Eaton Vance Ohio Municipal Income Trust MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
100.3% Upside
$14.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
520.00%
From $0.05 to $0.31 Per Share

Overall MarketRank™

New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.19 out of 5 stars

See Top Rated MarketRank™ Stocks Here
EVO stock logo

About Eaton Vance Ohio Municipal Income Trust Stock (NYSEAMERICAN:EVO)

Eaton Vance Ohio Municipal Income Trust is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. It invests in the fixed income markets. The fund invests primarily in debt securities issued by cogeneration, education, electric utilities, general obligations, hospital, industrial development, transportation, and water and sewer sectors. Eaton Vance Ohio Municipal Income Trust was formed in 1998 and is domiciled in United States.

EVO Stock News Headlines

April 17, 2024 | finance.yahoo.com
Evotec welcomes Aurélie Dalbiez as Chief People Officer
March 18, 2024 | finance.yahoo.com
Evotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%
April 18, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
January 10, 2024 | finance.yahoo.com
Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies
December 6, 2023 | finance.yahoo.com
Evotec-partner Jingxin Receives Approval for EVT201 in China
December 4, 2023 | finance.yahoo.com
Evotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%
November 15, 2023 | finance.yahoo.com
Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
November 7, 2023 | finance.yahoo.com
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
April 18, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
November 7, 2023 | finance.yahoo.com
Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
August 29, 2023 | finance.yahoo.com
Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
August 24, 2023 | seekingalpha.com
ETX Eaton Vance Municipal Income 2028 Term Trust
August 22, 2023 | finance.yahoo.com
Evotec SE Reports First Half-Year 2023 Results on 29 August 2023
July 28, 2023 | finance.yahoo.com
Evotec Provides Update on Financial Impact of Cyber-Attack
July 11, 2023 | finance.yahoo.com
Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership
July 5, 2023 | finance.yahoo.com
Just - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies Program
June 29, 2023 | finance.yahoo.com
Evotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease Programme
June 8, 2023 | finance.yahoo.com
UPDATE 1-European shares dip on rate jitters, banks rise
June 5, 2023 | finance.yahoo.com
Evotec Presents Sustainability Strategy
May 12, 2023 | finance.yahoo.com
Evotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023
May 9, 2023 | finance.yahoo.com
Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz
April 24, 2023 | finance.yahoo.com
Successful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit
April 17, 2023 | finance.yahoo.com
Evotec (ETR:EVT) pulls back 5.0% this week, but still delivers shareholders notable 6.1% CAGR over 5 years
April 7, 2023 | finance.yahoo.com
Cyber Attack on Evotec
March 21, 2023 | finance.yahoo.com
Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
February 10, 2023 | finance.yahoo.com
Evotec Receives € 150 m Loan from European Investment Bank
January 26, 2023 | finance.yahoo.com
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
See More Headlines
Receive EVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eaton Vance Ohio Municipal Income Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:EVO
Previous Symbol
NYSEMKT:EVO
CUSIP
N/A
CIK
N/A
Web
funds.eatonvance.com
Phone
+1-617-4828260
Fax
49-40-5608-1222
Employees
4,952
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.50
High Stock Price Target
$16.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+100.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.19
Trailing P/E Ratio
38.11
Forward P/E Ratio
144.80
P/E Growth
N/A
Net Income
$-185,070,000.00
Net Margins
-23.38%
Pretax Margin
-20.49%
Return on Equity
-13.93%
Return on Assets
-7.75%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
3.18
Quick Ratio
3.09

Sales & Book Value

Annual Sales
$791.73 million
Price / Sales
3.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.53 per share
Price / Book
2.05

Miscellaneous

Outstanding Shares
353,900,000
Free Float
N/A
Market Cap
$2.56 billion
Optionable
Not Optionable
Beta
1.35
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Payson F. Swaffield CFA
    VP, Chief Income Investment Officer & Portfolio Mang.
  • Mr. Paul M. O'Neil (Age 66)
    Chief Compliance Officer
  • Ms. Maureen Ann Gemma (Age 59)
    Chief Legal Officer, VP and Sec.
  • Mr. James F. Kirchner (Age 52)
    Treasurer
  • Ms. Cynthia J. Clemson (Age 56)
    Portfolio Mang.

Key Competitors

View All Competitors

EVO Stock Analysis - Frequently Asked Questions

Should I buy or sell Eaton Vance Ohio Municipal Income Trust stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eaton Vance Ohio Municipal Income Trust in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVO shares.
View EVO analyst ratings or view top-rated stocks.

What is Eaton Vance Ohio Municipal Income Trust's stock price target for 2024?

3 brokers have issued 1 year price targets for Eaton Vance Ohio Municipal Income Trust's stock. Their EVO share price targets range from $13.00 to $16.00. On average, they expect the company's stock price to reach $14.50 in the next year. This suggests a possible upside of 100.3% from the stock's current price.
View analysts price targets for EVO or view top-rated stocks among Wall Street analysts.

What other stocks do shareholders of Eaton Vance Ohio Municipal Income Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eaton Vance Ohio Municipal Income Trust investors own include Abeona Therapeutics (ABEO), AGNC Investment (AGNC), Enterprise Products Partners (EPD), Franklin Universal Trust (FT), (VNGBQ) (VNGBQ), (VNRSQ) (VNRSQ), Atlas Air Worldwide (AAWW), Ariana Resources (AAU), Atlantic Alliance Partnership (AAPCF) and AAON (AAON).

This page (NYSEAMERICAN:EVO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Urgent alert: open this for a huge profit potential
Timothy Sykes
Options trading has suddenly become more reliable.
Eagle Publishing
A.I. is a Tidal Wave - Here’s What to Buy
Chaikin Analytics